Pulmagen Therapeutics is a development stage pharmaceutical company progressing novel therapies to treat chronic respiratory diseases including asthma, severe asthma, and COPD. ** Click here for ERS 2013 Posters **

ss1 ss8 ss10 ss4 ss11 ss6 ss2 ss8 ss7

Pulmagen intends to progress its programs through Phase II proof-of-concept clinical trials and identify strategic partners for later stage clinical development.

The company has active partnered respiratory drug development programs with AstraZeneca, Chiesi, Dr. Reddy's, Skyepharma and Teijin.

Pulmagen Partners